XFOR

X4 Pharmaceuticals
$3.94
+$0.09 (+2.34%)Jul 27, 2026
2.0FairMoatMint rating

MoatMint rates X4 Pharmaceuticals (XFOR) 2.0 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.4 out of 10.

Key metrics

The numbers that frame XFOR today
Market cap
$371.62M
P/E (TTM)
-3.7
EV / FCF
-2.5
Gross margin
81.8%
EV / Sales
25.7
ROIC
-92.3%
Div yield
0%
Debt / equity
0.5
52wk Low
$1.35
52wk High
$4.83

XFOR stock rating

How XFOR scores on quality, value, growth, momentum and financial health
2.0out of 10
Fair overallNeutral business, expensive priceTop 80% of ~5,000 US stocks
QualityPoor0.4/10
GrowthPoor0.2/10
MomentumGreat8.5/10
ValuePoor0.9/10
Financial HealthNeutral5.1/10

Growth

Revenue and earnings trend for XFOR
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about XFOR
Is X4 Pharmaceuticals a good buy?
No. X4 Pharmaceuticals has excellent momentum, but poor quality undercuts the setup. Growth looks poor. That could put pressure on the long-term business case. We think X4 Pharmaceuticals is selling at a very high price.
What is the market capitalization of XFOR?
X4 Pharmaceuticals's market capitalization is $371.62M.
What is the P/E ratio for XFOR stock?
X4 Pharmaceuticals's current P/E ratio is -3.7.
What is the 52-week high for XFOR stock?
The 52-week high for X4 Pharmaceuticals is $4.83. The current close of $3.94 is 18.4% below that high.
What is the 52-week low for XFOR stock?
The 52-week low for X4 Pharmaceuticals is $1.35. The current close of $3.94 is 191.9% above that low.
Does XFOR stock pay dividends?
X4 Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XFOR?
X4 Pharmaceuticals's Debt / Equity ratio is 0.46.